- Home
- UNCY vs HQI Comparison
UNCY vs HQI Comparison
Compare UNCY & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | HQI |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 153.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UNCY | HQI |
|---|---|---|
| Price | $6.21 | $11.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $44.50 | $13.00 |
| AVG Volume (30 Days) | ★ 700.0K | 29.4K |
| Earning Date | 11-12-2025 | 03-26-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 412.84 |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | ★ $31,691,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.71 | $7.38 |
| 52 Week High | $11.00 | $15.75 |
Technical Indicators
Market Signals| Indicator | UNCY | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 54.09 |
| Support Level | $6.12 | $10.61 |
| Resistance Level | $6.94 | $11.97 |
| Average True Range (ATR) | 0.52 | 0.51 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 45.21 | 36.50 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.